5.7.2 Traditional Childhood Vaccine Safety Concerns

Recommendations

1. Improve Safety Testing:

• Mandate long-term, placebo-controlled trials using inert substances for all vaccines.

• Require independent research to assess the cumulative risks of vaccine components, including adjuvants, preservatives and the safety of combination vaccines.

• Until comprehensive safety testing is completed, a precautionary approach should be adopted. This includes limiting the use of certain vaccines in children, enhancing adverse event monitoring, and ensuring that parents receive full disclosure of both known and unknown risks to support informed decision-making.

2. Enhance Monitoring Systems:

• Revamp adverse event reporting systems like VAERS to ensure comprehensive and accurate tracking.

• Implement mandatory reporting requirements for healthcare providers to capture vaccine-related injuries effectively.

3. Reassess Adjuvant and Contaminant Safety:

• Conduct independent studies into the long-term neurological and developmental effects of aluminum adjuvants.

• Eliminate glyphosate contamination and harmful substances, such as aluminum, mercury and others from vaccines.

4. Enforce True Informed Consent and Parental Involvement:

• It is essential that healthcare providers receive comprehensive, evidence-based education on the full spectrum of vaccine-related information, including both the known benefits and risks, as well as the unknowns resulting from insufficient long-term safety studies and limited research on combined vaccine schedules. This education must also address concerns related to potentially harmful components, such as aluminum and other adjuvants, whose cumulative effects remain inadequately understood.

• Provide parents with clear, evidence-based information about vaccine risks and benefits.

• Empower parents to make informed decisions regarding the vaccination of their children based on individual health needs rather than standardized schedules.

• Ensure that vaccinations are no longer administered in schools to uphold parental authority and to prevent children from experiencing undue pressure, whether from school authority figures or from peer influence among classmates.

5. Strengthen Regulatory Oversight:

• Ensure independent oversight of vaccine safety evaluations to eliminate conflicts of interest.

• Increase transparency in clinical trial data, regulatory processes, and public health communications to restore trust.

• Hold pharmaceutical companies accountable for any harms their products cause.

6. Address Cumulative Risks:

• Develop guidelines to evaluate the cumulative effects of multiple vaccines administered within short time-frames.

• Prioritize research into the combined impacts of combination vaccines, environmental toxins, dietary factors, and vaccine components on children’s health.

7. Rebuild Trust and Accountability:

• Foster open dialogue with families and include parents and child development experts in policy-making processes.

• Promote ethical oversight to ensure vaccine policies prioritize the well-being of children over industry interests.

By implementing these recommendations, Canada can establish a safer, more transparent, and family-centred framework for childhood immunization. These changes are critical to addressing public concerns and protecting the health and future of Canadian children.